StockClub

SXTC

SXTCChina SXT Pharmaceuticals, Inc.$ --
China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc.

SXTC

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q4
Revenue
1M USD
YoY +163.0%
Operating Income
-1M USD
YoY +23.2%
Net Income
0M USD
YoY +113.1%
EPS
0.17$
YoY +133.3%

Revenue

$2.1M
FY2024 Q4$6.5M
$6.5M
Q4
FY2025 Q1$414,745
$414,745
Q1
FY2025 Q2$829,490
$829,490
Q2
FY2025 Q3$1.3M
$1.3M
Q3
FY2025 Q4$1.7M
$1.7M
Q4
FY2026 Q2$626,570
$626,570
Q2
FY2026 Q3$882,311
$882,311
Q3
FY2026 Q4$2.1M
$2.1M
Q4
Actual
+$339,879 (+19.5%)

Net Income

$-6.1M
FY2024 Q4$-3.1M
$-3.1M
Q4
FY2025 Q1$-401,284
$-401,284
Q1
FY2025 Q2$-802,568
$-802,568
Q2
FY2025 Q3$-2.1M
$-2.1M
Q3
FY2025 Q4$-3.3M
$-3.3M
Q4
FY2026 Q2$-6.4M
$-6.4M
Q2
FY2026 Q3$-6.3M
$-6.3M
Q3
FY2026 Q4$-6.1M
$-6.1M
Q4
Actual
$-2.8M (-85.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$4.8M
FY2021
$4.8M
FY2022
Actual:$2.6M
FY2022
$2.6M
FY2023
Actual:$2M
FY2023
$2M
FY2024
Actual:$1.9M
FY2024
$1.9M
FY2025
Actual:$1.7M
FY2025
$1.7M
FY2026
Actual:$1.1M
FY2026
$1.1M

Analyst Estimates

No forecast data